In order to find out what a atitude E. Coli-group would take toward streptomycin, following investigations were cart zed out: the amount of streptomycin which was excreted in feces, the manner of the growth of Coli-group, the resistance of Coli-group against strptomycin, and the relationship between clinical findings and streptomycin in feces. Nine intestinal tuberculosis patients and three nurses as control were subjected to these tests.
The results are as follows 1) During the course of treatment streptomycin was recovered in feces as: 100% of cases in which a diagnosis of intestinal tuberculosis was definitely proved, 75% of those clinically diagnosed, and 50% of those suspected for intestinal tuberculosis.
As the clinical symptoms improved, the exretion of streptomycin in feces was found decreased or absent; thus in those in which the diagnosis of intestinal tuberculosis was definitely proved the excretion of streptomycin was absent in 75%, and of the group of clinically diagnosed it was found absent in 66%.
The excretion of streptomycin was not observed in feces of healthy control.
The concentration of streptomycin excretion in feces was less than 6.25 γ/cc.
2) A slight drop in the number of Coli-group colonies found about 3 days after beginning of streptomycin treatment showed a return to the pretreatment number in 10 days.
3) The resistance of Coli-group against streptomycin was studied on 4 strains of E. Coli Type 1 which were recovered from the cases of proven intestinal tuberculosis. Coli-group were found to rapidly acquire the resistance against streptomycin. The detailed account an this score will be published shortly.
4) The fact that streptomycin is excreted only in patients of intestinal tuberculosis and is absent in healthy individuals seems to show that streptomycin may be advantageously used as a diagnostic means for intestinal tuberculosis.
View full abstract